Furthermore, TUBA1C was found to be a key mediator in the cell cycle-signaling pathways, which show aberrant expression in multifarious malignant tumors; tumor multiplication, migration, and invasion; and as a novel target for tumor-targeted therapy. The gene discussed is TUBA1C; the disease is cancer.